Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia.

<h4>Background</h4>Visceral leishmaniasis (VL) is one of the most neglected tropical infectious diseases. It is fatal if left untreated. The objective of this study was to assess the efficacy and safety of 17-day injections of combined regimen of sodium stibogluconate and paromomycin (SS...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Aschalew Tamiru, Rezika Mohammed, Saba Atnafu, Girmay Medhin, Asrat Hailu
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
Accès en ligne:https://doaj.org/article/f95ac388400044ab8793649b60e58e03
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!